ZA200401217B - Zero order controlled drug delivery system. - Google Patents

Zero order controlled drug delivery system.

Info

Publication number
ZA200401217B
ZA200401217B ZA200401217A ZA200401217A ZA200401217B ZA 200401217 B ZA200401217 B ZA 200401217B ZA 200401217 A ZA200401217 A ZA 200401217A ZA 200401217 A ZA200401217 A ZA 200401217A ZA 200401217 B ZA200401217 B ZA 200401217B
Authority
ZA
South Africa
Prior art keywords
delivery system
drug delivery
zero order
controlled drug
order controlled
Prior art date
Application number
ZA200401217A
Other languages
English (en)
Inventor
John Richard Langridge
Tian Wei Lawal Olyainka
Original Assignee
Phoqus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoqus Pharmaceuticals Ltd filed Critical Phoqus Pharmaceuticals Ltd
Publication of ZA200401217B publication Critical patent/ZA200401217B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ZA200401217A 2001-07-19 2004-02-16 Zero order controlled drug delivery system. ZA200401217B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0117619.7A GB0117619D0 (en) 2001-07-19 2001-07-19 Pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
ZA200401217B true ZA200401217B (en) 2005-03-10

Family

ID=9918809

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200401217A ZA200401217B (en) 2001-07-19 2004-02-16 Zero order controlled drug delivery system.

Country Status (14)

Country Link
US (1) US20050106251A1 (ja)
EP (1) EP1406596A1 (ja)
JP (1) JP4571799B2 (ja)
KR (1) KR20040029373A (ja)
CN (1) CN1556696A (ja)
AU (1) AU2002317363B2 (ja)
BR (1) BR0211157A (ja)
CA (1) CA2457304A1 (ja)
GB (1) GB0117619D0 (ja)
IL (1) IL159875A0 (ja)
MX (1) MXPA04000545A (ja)
RU (1) RU2004104952A (ja)
WO (1) WO2003007918A1 (ja)
ZA (1) ZA200401217B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
GB0204772D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Pharmaceutical dosage forms
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
JP2006520390A (ja) * 2003-03-14 2006-09-07 ムルイェ、ニルマル 徐放性錠剤の製造方法
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2005067887A2 (en) * 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US7390524B1 (en) 2004-05-20 2008-06-24 Advanced Cardiovascular Systems, Inc. Method for electrostatic spraying of an abluminal stent surface
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
WO2009146537A1 (en) * 2008-06-02 2009-12-10 Pharmascience Inc. Multilayer control-release drug delivery system
WO2010017821A1 (en) * 2008-08-14 2010-02-18 Daniel Bar-Shalom Coated tablets with a remaining degradation surface over the time8
WO2010026467A2 (en) * 2008-09-04 2010-03-11 Torrent Pharmaceuticals Ltd. Controlled release dosage form of high solubility active ingredient
BR112012022775A2 (pt) * 2010-03-10 2016-07-19 Nogra Pharma Ltd composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas
CN103097466A (zh) * 2010-03-15 2013-05-08 大正制药株式会社 颜料组合物
US9333175B2 (en) * 2010-06-16 2016-05-10 Mylan Inc. Controlled release levetiracetam formulations and methods for producing the same
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
US20180344649A1 (en) 2015-09-29 2018-12-06 Acorda Therapeutics, Inc. Sustained release compositions of 4-aminopyridine
KR102209420B1 (ko) * 2019-03-08 2021-01-29 에이치엘비제약 주식회사 리바스티그민의 일정한(0-차) 방출형 경구용 서방성 정제 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
GB2253164B (en) * 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
ATE293440T1 (de) * 1995-05-09 2005-05-15 Phoqus Pharmaceuticals Ltd Pulverbeschichtungszusammensetzung für elektrostatische beschichtung von pharmazeutischen substraten
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
GB9929946D0 (en) * 1999-12-17 2000-02-09 Phoqus Limited Electrostatic application of powder material to solid dosage forms
GB0002305D0 (en) * 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application

Also Published As

Publication number Publication date
IL159875A0 (en) 2004-06-20
CN1556696A (zh) 2004-12-22
WO2003007918A1 (en) 2003-01-30
CA2457304A1 (en) 2003-01-30
EP1406596A1 (en) 2004-04-14
JP2005506318A (ja) 2005-03-03
RU2004104952A (ru) 2005-03-10
US20050106251A1 (en) 2005-05-19
JP4571799B2 (ja) 2010-10-27
BR0211157A (pt) 2004-08-10
GB0117619D0 (en) 2001-09-12
KR20040029373A (ko) 2004-04-06
MXPA04000545A (es) 2005-06-06
AU2002317363B2 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
HUP0401438A3 (en) Drug delivery system
ZA200401217B (en) Zero order controlled drug delivery system.
HK1077523A1 (en) Proliposomal drug delivery system
ZA200401216B (en) Controlled drug delivery systems providing variable release rates.
EP1379291A4 (en) INTEGRATED DRUG DELIVERY SYSTEM
HUP0500795A3 (en) Gastric retention controlled drug delivery system
IL155272A0 (en) Systems for optimized drug delivery
GB2421689B (en) Drug delivery system
HK1048427A1 (en) Drug delivery device.
HK1036230A1 (en) Drug delivery devices.
ZA200107123B (en) Oral drug delivery system.
HK1053217A1 (en) Short message delivery system.
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
PL376169A1 (en) Drug delivery system
GB0103877D0 (en) Novel Drug Delivery system
MXPA03007124A (es) Sistemas para el suministro de farmaco con objetivo anti-tumor.
ZA200409726B (en) Monocompartment osmotic controlled drug delivery system.
GB0029843D0 (en) Drug delivery system
AU2002210580A1 (en) Drug delivery system
GB0102725D0 (en) Medical delivery system
GB0112326D0 (en) Drug delivery system
GB0115136D0 (en) Drug delivery system
AU2002228323A1 (en) Spaced drug delivery system
GB0113857D0 (en) Delivery system
AU2002246571A1 (en) Drug delivery systems